Search

9613 results for: ‘map’

  • People

    Browse a list of the academic and professional services staff working within the Victorian Studies Centre, and see their contact details.

  • 2022

    An archive listing of the spring seminar events of 2022.

  • Barbara Cooke: Page 2

    Research Associate for the Complete Works of Evelyn Waugh project.

  • Cancer Therapeutics

    Module code: MB7403 ‘Cancer therapeutics’ takes an in-depth look at the changing ways we approach cancer treatment, and discusses the ethical issues surrounding cancer research and treatment.

  • Advanced Topics in Cancer Biology

    Module code: MB7004 The development and use of appropriate anti-cancer therapy rely on the accurate diagnosis of cancer. Therefore, it is important to be able to differentiate between normal and malignant tissue under the microscope.

  • Advanced Topics in Cancer Biology

    Module code: MB7004 The development and use of appropriate anti-cancer therapy rely on the accurate diagnosis of cancer. Therefore, it is important to be able to differentiate between normal and malignant tissue under the microscope.

  • Cancer Therapeutics

    Module code: MB7403 ‘Cancer therapeutics’ takes an in-depth look at the changing ways we approach cancer treatment, and discusses the ethical issues surrounding cancer research and treatment.

  • Advanced Topics in Cancer Biology

    Module code: MB7004 The development and use of appropriate anti-cancer therapy rely on the accurate diagnosis of cancer. Therefore, it is important to be able to differentiate between normal and malignant tissue under the microscope.

  • Cancer Therapeutics

    Module code: MB7403 ‘Cancer therapeutics’ takes an in-depth look at the changing ways we approach cancer treatment, and discusses the ethical issues surrounding cancer research and treatment.

  • Leicester spinout technology hailed as most commercially viable

    A technology developed at the University, and the prime focus of Leicester spin-out company MIP Diagnostics, has been recognised as ‘most commercially viable’ at Europe’s flagship Drug Discovery event.

Back to top
MENU